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Background: We have previously shown that the slow Wallerian degeneration mutation, whilst delaying axonal
degeneration after optic nerve crush, does not protect retinal ganglion cell (RGC) bodies in adult rats. To test the
effects of a combination approach protecting both axons and cell bodies we performed combined optic nerve
crush and lens injury, which results in both enhanced RGC survival as well as axon regeneration past the lesion site
in wildtype animals.
Results: As previously reported we found that the WldS mutation does not protect RGC bodies after optic nerve
crush alone. Surprisingly, we found that WldS transgenic rats did not exhibit the enhanced RGC survival response
after combined optic nerve crush and lens injury that was observed in wildtype rats. RGC axon regeneration past
the optic nerve lesion site was, however, similar in WldS and wildtypes. Furthermore, activation of retinal glia,
previously shown to be associated with enhanced RGC survival and axon regeneration after optic nerve crush and
lens injury, was unaffected in WldS transgenic rats.
Conclusions: RGC axon regeneration is similar between WldS transgenic and wildtype rats, but WldS transgenic rats
do not exhibit enhanced RGC survival after combined optic nerve crush and lens injury suggesting that the
neuroprotective effects of lens injury on RGC survival may be limited by the WldS protein.
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The visual system provides an excellent model for study-
ing neuronal survival and axon regeneration after central
nervous system injury. Following optic nerve lesion, axo-
tomised adult rat retinal ganglion cells (RGC) die in
large numbers. The surviving RGC only show a transient
sprouting reaction with very limited axon growth past
the lesion site [1]. However, it has been found that RGC
survival and axon regeneration past the optic nerve le-
sion site can be enhanced, for example by lens injury
[2-4], peripheral nerve injury [1,4], or intravitreal zymo-
san injection [2]. This is correlated with invasion of
macrophages into the eye and activation of retinal glia,
astrocytes and Müller glia [2,4,5], which produce a* Correspondence: krgm2@cam.ac.uk
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reproduction in any medium, provided the orvariety of growth factors, including oncomodulin [6,7]
and ciliary neurotrophic factor/apolipoprotein E respect-
ively [5,8]. The role of macrophages in mediating RGC
survival and axon regeneration has recently been chal-
lenged [9] and activated retinal glia have been shown to
be important mediators of this response [5,8].
We have previously shown that the slow Wallerian de-
generation mutation (WldS) delays RGC axon degener-
ation in adult rats after optic nerve injury, but does not
reduce cell body death compared to wildtype animals
[10]. To test the effects of a combination approach pro-
tecting both axons and cell bodies we performed com-
bined optic nerve crush and lens injury, which enhances
RGC survival as well as axon regeneration in wildtype
rats [2-4]. This is also of particular interest in terms of
the effects of the WldS mutation on the axon regener-
ation potential in the central nervous system (CNS) be-
cause previous studies have mainly focused on peripheralLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mutation first arose [11,12]. Whilst there have been
reports that axonal regeneration is impaired in WldS
transgenic mice, it has also been shown that they are able
to regenerate normally in an appropriate environment
[11,13,14].
Interestingly, we found that whilst optic nerve crush
and lens injury did not lead to enhanced RGC survival in
WldS transgenic rats, these cells were nevertheless able to
successfully re-grow RGC axons past the optic nerve le-
sion site.
Results
We have previously confirmed that transgenic WldS rat
RGC express the WldS protein, and that their axons
show delayed Wallerian degeneration after optic nerve
crush [10].
RGC axon regeneration
Two weeks after optic nerve crush alone, only a small
number of adult rat RGC axons were able to grow past
the optic nerve lesion site in both wildtype and WldS
transgenic rats with no significant difference between
the two (Figure 1A-C). However, optic nerve crush com-
bined with lens injury significantly increased the number
of RGC axons crossing the optic nerve lesion site and
growing into the distal optic nerve stump at 14 days
post-injury. This regeneration response, whilst appearing
slightly stronger in wildtype rats (wildtype: P< 0.01,
WldS: P< 0.05 versus optic nerve crush), was not signifi-
cantly different to that found in WldS transgenic rats
(Figure 1A,D,E). Therefore, RGC axon regeneration was
similar between wildtype and WldS transgenic rats.
RGC survival
For ease of RGC identification we used Islet-1, which is
expressed by RGC as well as by displaced amacrine cells
in the ganglion cell layer. Islet-1 is also expressed by
some cells in the inner nuclear layer [15,16]. However,
as it was previously shown that amacrine cells are not
affected by optic nerve lesions [17,18], changes in Islet-1
labelling in the ganglion cell layer are likely to be due to
changes in the number of surviving RGC, though we
can not exclude that lens injury may have had an effect
on amacrine survival.
We found that, as previously reported [10], two weeks
after optic nerve crush, RGC survival was reduced to a
third of control retinas and did not differ between wild-
type and WldS transgenic rats. Interestingly, whilst lens
injury at the time of optic nerve crush led to a signifi-
cant increase in RGC survival (P< 0.01) in wildtype rats,
it did not affect RGC survival in WldS transgenic rats
(Figure 2A-G). Thus, whilst RGC survival was similar in
both genotypes following optic nerve crush alone, opticnerve crush combined with lens injury revealed that, in
contrast to wildtypes, no enhanced RGC survival re-
sponse occurred in WldS transgenic rats.
Retinal glia activation
In both untreated wildtype and WldS transgenic rats ex-
pression of glial fibrillary acidic protein (GFAP) was
restricted to astrocytic processes in the nerve fibre layer of
the retina (Figure 3B,C). In both genotypes, fourteen days
after optic nerve crush alone occasional Müller glia had
become activated as evidenced by increased GFAP expres-
sion, with cell processes crossing the retinal layers (Fig-
ure 3A,D,E). Combination of optic nerve crush with lens
injury led to a significant increase in retinal glia activation
over that observed in optic nerve crush alone, in both
wildtype (P< 0.001) and WldS transgenic rats (P< 0.001)
with pronounced GFAP expression visible in Müller glia
throughout the retina (Figure 3A,F,G). Retinal glia activa-
tion after optic nerve crush was not significantly different
between WldS transgenic and wildtype rats. Thus, activa-
tion of retinal glia occurred to a similar extent in wildtype
and WldS transgenic rats.
Discussion
The WldS mutation has long been linked with delayed
Wallerian degeneration in the PNS and CNS after injury
[10-12] but relatively few studies have looked at the axon
regenerative potential in WldS transgenic animals. Al-
most all of these studies have focused on WldS trans-
genic mice and investigated the regeneration potential
after peripheral nerve injury [11,13,14], with only one
study looking at recovery after injury to the CNS. Whilst
this study found that locomotor recovery after partial
spinal cord injury was delayed in WldS transgenic mice,
it was suggested that the speed with which recovery oc-
curred in wildtype mice was likely to result from
changes in functional plasticity rather than axon regen-
eration [19].
The present study is therefore the first to look at axon
regeneration of WldS transgenic rats, a recently gener-
ated strain [20], after injury to the CNS using a unique
model, the optic nerve crush model, in which it is pos-
sible to stimulate successful RGC axon regeneration in
wildtype rats when optic nerve crush is combined with
lens injury [2-4]. Interestingly, we found that whilst the
regeneration response was slightly stronger in wildtype
rats, WldS transgenic rats were able to successfully grow
RGC axons past the optic nerve lesion site after optic
nerve crush and lens injury, with regeneration not being
significantly different from wildtypes. We also found that
activation of retinal glia, previously shown to mediate
RGC survival and axon regeneration response after optic
nerve crush and lens injury in wildtype rats [5,8], oc-
curred to a similar extent between WldS transgenic and
Figure 1 RGC axon regeneration is similar between WldS transgenic and wildtype rats after optic nerve crush and lens injury.
(A) Quantification of the mean number of RGC axons extending 250 μm past the optic nerve lesion site 14 days after either optic nerve crush
alone, or in combination with lens injury in adult wildtype or WldS transgenic rats. Significant differences are indicated by asterisk (P< 0.05 = *;
P< 0.01 = **). Images of RGC axon regeneration past the optic nerve lesion site (indicated by asterisk), 14 days after (B, C) optic nerve crush alone
or (D, E) in combination with lens injury in wildtype and WldS transgenic rats. WT=Wildtype; ONC=Optic nerve crush; ONC+ LI =Optic nerve
crush + lens injury; Scale bars: 100 μm.
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axon regeneration can indeed occur in WldS transgenic
rats.
Delayed Wallerian degeneration in the CNS compared
to the PNS has long been associated with axon regenera-
tive failure after CNS injury [21]. We have recently
shown that in WldS transgenic rats Wallerian degener-
ation after optic nerve injury is also delayed [10]. Suc-
cessful RGC axon regeneration through the normally
inhibitory environment of the distal optic nerve in wild-
type rats after lens injury has been associated with an
altered growth-disinhibitory phenotype, potentially
through release of metalloproteinases from regeneratingRGC axons, which degrade myelin-derived inhibitory
ligands in the distal optic nerve stump [22]. This may
also explain why successful RGC axon regeneration
induced by lens injury can occur in WldS transgenic rats
where Wallerian degeneration is even further delayed.
Our findings are in line with a study in WldS transgenic
mice where the WldS mutation did not appear to alter the
growth phenotype compared to wildtype mice, as sensory
dorsal root ganglion axons regenerated normally, al-
though only in an optimal environment where Wallerian
degeneration was experimentally enhanced [14].
Whilst RGC axon regeneration past the optic nerve le-
sion site was similar between WldS transgenic rats and
Figure 2 Enhanced RGC survival does not occur in WldS transgenic rats after optic nerve crush and lens injury. (A) Percentage of
surviving RGC (compared to control) 14 days after either optic nerve crush alone or in combination with lens injury in adult wildtype and WldS
transgenic rats. Significant differences are indicated by asterisk (P< 0.01 = **). Cross-sections through adult wildtype or WldS retinae stained for
Islet-1 (to identify RGC in the ganglion cell layer) from (B, C) control (untreated), or 14 days after (D, E) optic nerve crush, or (F, G) optic nerve
crush in combination with lens injury. GC=Ganglion cell layer; IP = Inner plexiform layer; IN = Inner nuclear layer; WT=Wildtype; ONC=Optic
nerve crush; ONC+ LI =Optic nerve crush + lens injury; Scale bars: 50 μm.
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survival that occurred in wildtype rats after optic nerve
crush and lens injury did not occur in WldS transgenic
rats. These results could be consistent with WldS trans-
genic rats indeed having an enhanced RGC axon regen-
eration potential compared to wildtype rats, but this will
need to be investigated more fully in future studies. It
may seem surprising that, despite an absence of
enhanced RGC survival in WldS transgenic rats after
optic nerve crush and lens injury, successful RGC axon
regeneration past the lesion site occurred. However, this
finding is consistent with other studies which show thatsurvival and regeneration are not linked per se, and that
these two responses to injury appear to be regulated in-
dependently and can be modulated by distinct intracellu-
lar pathways [23,24].
As previously reported [10], RGC survival two weeks
after optic nerve crush alone was similarly reduced to a
third of control eyes in both wildtype and WldS trans-
genic rats, suggesting that there is no somatic RGC pro-
tection conferred through WldS in this model. This is in
line with another study [25] which showed that there
was no direct protective effect on cell bodies after induc-
tion of cell death in L4 motoneurons in WldS transgenic
Figure 3 Retinal glia activation is similar between WldS transgenic and wildtype rats after optic nerve crush and lens injury.
(A) Retinal glia activation (measured as percentage increase in GFAP intensity compared to control; control set as 100% baseline) 14 days after
either optic nerve crush alone or in combination with lens injury in adult wildtype and WldS transgenic rats. Significant differences are indicated
by asterisk (P< 0.001= ***). Cross-sections through adult wildtype or WldS retinae stained for presence of GFAP+ astrocytes (arrowheads)/Müller
glia (open arrowheads) from (B, C) control (untreated), or 14 days after (D, E) optic nerve crush, or (F, G) optic nerve crush in combination with
lens injury. The RGC layer is marked in panel B by an asterisk. WT=Wildtype; ONC=Optic nerve crush; ONC+ LI =Optic nerve crush + lens injury;
Scale bars: 50 μm.
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in other injury models [12,26] was most likely due to
secondary axonal protection. Whilst we did not observe
a neuroprotective effect of the WldS protein on RGC
survival in this and a previous study [10] after optic
nerve crush, it is possible that secondary axonal protec-
tion may have made RGC from WldS transgenic rats less
responsive to survival factors released in response to
lens injury.
Several mechanisms have been suggested to mediate
neuroprotection in WldS transgenic animals and it willbe interesting to investigate in future if they interfere
with RGC survival pathways activated through lens in-
jury, thereby rendering the latter inactive in WldS trans-
genic rats. WldS is a fusion protein that consists of
nicotinamide mononucleotide adenylyl-transferase-1
(Nmnat1) and a short fragment of the ubiquitin assem-
bly protein UFD2. Whilst several reports have suggested
that Nmnat is the key mediator of the neuroprotective
WldS effects through upregulation of nicotinamide aden-
ine dinucleotide levels, there are some reports that have
challenged this view reviewed in [27,28]. Other proposed
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tection include changes in gene expression, such as
downregulation of the pituitary tumor transforming gene
[29], or changes in the regulation of the cell cycle status
which may “prime” neurons against future neurodegen-
erative insults by modifying endogenous stress pathways
[30]. The latter findings were observed in uninjured
WldS mouse cerebella so it will be interesting to examine
to what extent changes in cell cycle status occur in WldS
transgenic RGC and to study the effects that optic nerve
crush and lens injury has on them.
There is, therefore, an array of mechanisms that have
been suggested to underlie WldS mediated neuroprotec-
tion, with most studies however conducted in WldS
transgenic mice [27]. It will be important to explore in
future studies whether the same mechanisms are present
in WldS transgenic rats. In that respect it will also be im-
portant to investigate further the role that non-neuronal
retinal cells play, in particular glial cells which are med-
iators of the neuroprotective responses after lens injury
[5,8]. The majority of proteins implicated in mediating
mechanisms underlying neuroprotection in WldS trans-
genic animals are located in transgenic WldS neurons
and their axons, with only some weak expression
observed in glia [29,31]. In contrast to WldS transgenic
mice, we previously found that retinal WldS expression
also localizes to cells of the inner nuclear rat retina [10],
an area where Müller glia cell bodies are also located. It
will therefore be important to determine whether the ex-
pression of WldS and its downstream effector proteins
indeed correlate to Müller glia, and whether optic nerve
crush combined with lens injury modulates their expres-
sion. Such future investigations will further our under-
standing of the mechanisms that underlie the RGC
survival and axon regeneration responses in the WldS
transgenic rat model.
Conclusions
In summary we have shown that whilst RGC axon re-
generation is similar between WldS transgenic and wild-
type rats, somatic RGC protection is not conferred
through, and may indeed be limited, by the WldS protein
following optic nerve crush and lens injury. It will be
important to investigate in future studies the mechan-
isms that underlie these effects, and to identify combin-
ation treatments that both protect cell bodies and
enhance RGC axon regeneration in WldS transgenic rats.
Methods
Surgical procedures
Animals
All animal experiments were conducted in accordance
with the U.K. Home Office regulations for the care and
use of laboratory animals, the U.K. Animals (ScientificProcedures) Act (1986) and the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Homozygous young adult, 2-3 month old, male WldS
transgenic rats (n = 31) from line 79, in which the WldS
cDNA transgene is driven by a β-actin promoter [20,25],
or age-matched Sprague Dawley rats (n = 27; Charles
River, Margate, UK) which are the background strain the
WldS rats arose from [20], were used for this study. Ani-
mals were kept in a pathogen controlled environment
on a 12 hour light–dark cycle in standard cages and
allowed to feed and drink ad libitum.
For in vivo experiments rats were assigned to three
groups: optic nerve crush (n = 8; Sprague Dawley; n = 9;
WldS), optic nerve crush + lens injury (n = 11; Sprague
Dawley; n = 13; WldS), untreated (control; n = 8 Sprague
Dawley; n = 9; WldS).
Optic nerve crush and lens injury
Rats were anesthetized by intraperitoneal injection of
ketamine (75 mg/kg) and domitor (medetomidine
hydrochloride; 0.5 mg/kg). Analgesics (Buprenorphine
0.03 mg/kg) were administered pre- and post-surgery.
Unilateral optic nerve crush was performed as previously
described [1], avoiding injury to the retinal artery in the
dural sheath (confirmed by indirect ophthalmoscopy) by
incising the dorsum of the latter longitudinally before
crushing the optic nerve. The lens was injured at the
time of the optic nerve crush by inserting the tip of a 25
gauge needle into the eye 2 mm anterior to the nerve
head, perpendicular to the sclera to puncture the lens to
a depth of about 2 mm. Lens injury was confirmed by
direct visualization through the cornea.
Immunohistochemistry on tissue sections
Animals were transcardially perfused 14 days post-injury
under terminal anaesthesia with 0.1 M phosphate buf-
fered saline (PBS) followed by 4% paraformaldehyde.
Eyes and optic nerves were removed and post-fixed by
immersion overnight in cold 4% paraformaldehyde. Tis-
sue was then washed with PBS and transferred to 30%
sucrose solution (overnight at 4 °C) for cryoprotection
and embedded in OCT mounting medium (Raymond A.
Lamb, Eastbourne, UK). Serial sections, 14 μm thick,
were cut with a cryostat, thaw-mounted onto glass slides
(Superfrost plus, VWR, Lutterworth, UK) and stored at
-20 °C until further use.
Rehydrated eye sections were incubated in blocking solu-
tion (4% goat serum; 0.3% Triton (Sigma) in PBS) for
60 min at room temperature. Primary antibodies were ap-
plied overnight at 4 °C in blocking solution: mouse anti-
Islet-1 homeobox (39.4D5 concentrate; 1:2000; hybridoma
developed by T. Jessell and S. Brenner-Morton, concentrate
from the Developmental Studies Hybridoma Bank, The
University of Iowa, Iowa City, IA) and rabbit anti-GFAP
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well as by displaced amacrine cells in the ganglion cell layer
[15,16]. GFAP is a marker for activated astrocytes/Müller
glia [32]. The following day, slides were washed 3 x 10 min
in PBS and secondary antibodies (Alexa Fluor 488 goat
anti-rabbit IgG; 1/1000 and Alexa Fluor 555 goat anti-
mouse IgG; 1/1000, Invitrogen, Paisley, UK) were applied
for 2 hrs at room temperature in blocking solution. Follow-
ing 3 x 10 min washes in PBS, slides were mounted in
Fluorsave (Calbiochem/Merck Chemicals, Beeston, UK).
Immunohistochemistry was carried out to visualize
growth-associated membrane phosphoprotein-43 (GAP-43)
positive axons in optic nerve sections as previously described
[2]. GAP-43 is normally not detected in the mature optic
nerve, but it is strongly upregulated in regenerating RGC to
fill the somata and axons [1,2,33]. As primary antibody the
IgG fraction from an anti-GAP-43 antiserum prepared in
sheep (1:2500; [34]) followed by an Alexa Fluor 488 second-
ary antibody against sheep IgG (1:1000, Invitrogen) were
used.
Quantification of RGC survival/axon regeneration and
retinal glia activation
Quantification of GAP-43 positive RGC axon growth in the
distal optic nerve stump was based on a previously
described method [1]. Briefly, axon growth was quantified
by counting the number of GAP-43 positive axons extend-
ing 250 μm from the crush site into the distal optic nerve
in four longitudinal sections per optic nerve, using a stand-
ard epifluorescence microscope (model DM6000B; Leica,
Wetzlar, Germany). The cross-sectional width of the nerve
was measured at the point at which the counts were taken
and was used to calculate the number of axons per milli-
metre of nerve width. The number of axons was then aver-
aged over the four sections.
P
ad, the total number of
axons extending distance d in a nerve having a radius of r,
was estimated by summing over all sections having a thick-
ness t (14 μm):
P
ad = πr
2 x [average axons/mm]/t.
To evaluate RGC survival, the number of Islet-1+ cells
were counted in 4 sections throughout the eye and nor-
malised to 100 μm retinal section length. Results are
expressed as percentage difference versus control (con-
trol set as 100% baseline). For measuring activation of
retinal glia, images of GFAP staining were taken along
the retina in 4 sections throughout the eye, and the pixel
intensity quantified using the Leica Application Suite
(LAS AF.1.8.0) program. Results are expressed as per-
centage difference in GFAP activation versus control
(control set as 100% baseline).
Results are expressed as mean±SEM of 8-13 rats per con-
dition for each of the experimental groups. The significance
of intergroup differences was evaluated by an unpaired two-
tailed t test (assuming equal variances) and considered signifi-
cant at P< 0.05 (P< 0.05= *; P< 0.01= **; P< 0.001=***).Abbreviations
CNS: Central nervous system; GAP-43: Growth-associated membrane
phosphoprotein-43; GFAP: Glial fibrillary acidic protein; Nmnat1: Nicotinamide
mononucleotide adenylyl-transferase-1; PBS: Phosphate buffered saline;
PNS: Peripheral nervous system; RGC: Retinal ganglion cell; SEM: Standard
error of the mean; WldS: Slow Wallerian degeneration mutation.
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